title: Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice.
abstract: Theiler's murine encephalomyelitis virus (TMEV)-induced immune-mediated demyelinating disease in susceptible mouse strains has been extensively investigated as a relevant model for human multiple sclerosis. Previous investigations of antiviral T-cell responses focus on immune responses to viral capsid proteins, while virtually nothing is reported on immune responses to nonstructural proteins. In this study, we have identified noncapsid regions recognized by CD4(+) T cells from TMEV-infected mice using an overlapping peptide library. Interestingly, a greater number of CD4(+) T cells recognizing an epitope (3D(21-36)) of the 3D viral RNA polymerase, in contrast to capsid epitopes, were detected in the CNS of TMEV-infected SJL mice, whereas only a minor population of CD4(+) T cells from infected C57BL/6 mice recognized this region. The effects of preimmunization and tolerization with these epitopes on the development of demyelinating disease indicated that capsid-specific CD4(+) T cells are protective during the early stages of viral infection, whereas 3D(21-36)-specific CD4(+) T cells exacerbate disease development. Therefore, protective versus pathogenic CD4(+) T-cell responses directed to TMEV appear to be epitope dependent, and the differences in CD4(+) T-cell responses to these epitopes between susceptible and resistant mice may play an important role in the resistance or susceptibility to virally induced demyelinating disease.
authors.affiliation: Department of Microbiology-Immunology and Neuroscience Institute, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611, USA.
authors.forename: Young-Hee
authors.initials: YH
authors.lastname: Jin
authors.forename: Bongsu
authors.initials: B
authors.lastname: Kang
authors.forename: Byung S
authors.initials: BS
authors.lastname: Kim
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D018188:Cardiovirus Infections / Q000276:immunology / Q000821:virology; D002460:Cell Line; D012321:DNA-Directed RNA Polymerases / Q000235:genetics / Q000276:immunology*; D003711:Demyelinating Diseases / Q000276:immunology / Q000473:pathology / Q000821:virology; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D010455:Peptides / Q000235:genetics / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology; D017945:Theilovirus / Q000276:immunology*; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*
chemical_list: D000939:Epitopes; D010455:Peptides; D014764:Viral Proteins; D012321:DNA-Directed RNA Polymerases
references.citation: J Virol. 1997 Jul;71(7):5244-50
references.pmid: 9188592
references.citation: J Virol. 2008 Dec;82(23):11545-54
references.pmid: 18815294
references.citation: Eur J Immunol. 1993 Sep;23(9):2287-93
references.pmid: 8370406
references.citation: Nat Med. 1997 Dec;3(12):1394-7
references.pmid: 9396611
references.citation: J Immunol. 1997 Jan 1;158(1):127-35
references.pmid: 8977183
references.citation: J Neurol Sci. 1976 Nov;30(1):201-7
references.pmid: 978224
references.citation: J Immunol. 1995 Nov 1;155(9):4497-503
references.pmid: 7594613
references.citation: J Exp Med. 1998 Jun 15;187(12):2055-63
references.pmid: 9625765
references.citation: Mol Immunol. 1994 Aug;31(11):803-12
references.pmid: 7519304
references.citation: Vaccine. 2003 Oct 1;21(27-30):4261-9
references.pmid: 14505908
references.citation: J Immunol. 1995 Jul 15;155(2):947-57
references.pmid: 7608570
references.citation: J Virol. 1998 Jul;72(7):6169-74
references.pmid: 9621084
references.citation: Adv Exp Med Biol. 1993;342:413-8
references.pmid: 7911644
references.citation: J Immunol. 1985 Sep;135(3):2145-8
references.pmid: 2991380
references.citation: J Virol. 1998 May;72(5):4515-9
references.pmid: 9557751
references.citation: Ann Allergy. 1990 May;64(5):433-44
references.pmid: 2186672
references.citation: Neurology. 1984 Aug;34(8):1117-9
references.pmid: 6087205
references.citation: Eur J Immunol. 2006 Aug;36(8):2106-15
references.pmid: 16761311
references.citation: Eur J Immunol. 2004 Oct;34(10):2730-9
references.pmid: 15368289
references.citation: J Neurovirol. 2001 Oct;7(5):409-20
references.pmid: 11582513
references.citation: J Virol. 2007 Jun;81(12):6584-93
references.pmid: 17428853
references.citation: J Neuroimmunol. 2001 Jul 2;117(1-2):166-70
references.pmid: 11431017
references.citation: J Immunol. 2002 Apr 15;168(8):4221-30
references.pmid: 11937584
references.citation: Virology. 2004 May 1;322(2):264-75
references.pmid: 15110524
references.citation: J Immunol. 2006 Nov 15;177(10):6705-12
references.pmid: 17082583
references.citation: J Virol. 1998 Feb;72(2):1020-7
references.pmid: 9444995
references.citation: Arch Immunol Ther Exp (Warsz). 2000;48(5):373-9
references.pmid: 11140464
references.citation: J Virol. 1997 Jul;71(7):5361-5
references.pmid: 9188606
references.citation: J Virol. 1995 Nov;69(11):7315-8
references.pmid: 7474161
references.citation: Ann Neurol. 1983 Apr;13(4):426-33
references.pmid: 6340596
references.citation: J Neuropathol Exp Neurol. 1993 Mar;52(2):95-105
references.pmid: 8440999
references.citation: Int Immunol. 1994 May;6(5):721-30
references.pmid: 8080842
references.citation: Immunology. 1995 Jun;85(2):190-7
references.pmid: 7543873
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14124-9
references.pmid: 18768820
references.citation: Eur J Immunol. 1993 Jan;23(1):46-55
references.pmid: 8419186
references.citation: J Immunol. 1994 Jan 15;152(2):908-18
references.pmid: 7904291
references.citation: J Neuroimmunol. 2001 Aug 30;118(2):256-67
references.pmid: 11498260
references.citation: Nat Genet. 1993 Sep;5(1):87-91
references.pmid: 8220433
references.citation: J Neurosci. 1998 Sep 15;18(18):7306-14
references.pmid: 9736651
references.citation: Nat Med. 1998 Feb;4(2):187-193
references.pmid: 9461192
references.citation: J Immunol. 1993 Jul 1;151(1):266-76
references.pmid: 8326128
references.citation: J Virol. 2002 Jul;76(13):6577-85
references.pmid: 12050370
references.citation: PLoS Pathog. 2007 Aug 24;3(8):e124
references.pmid: 17722981
references.citation: J Virol. 2002 Apr;76(7):3125-34
references.pmid: 11884537
references.citation: J Neuroimmunol. 2001 Jun 1;116(2):125-35
references.pmid: 11438167
references.citation: J Immunol. 1995 Nov 15;155(10):5003-10
references.pmid: 7594507
references.citation: J Virol. 1993 Jan;67(1):589-92
references.pmid: 8416386
references.citation: J Virol. 2007 Nov;81(21):11690-702
references.pmid: 17715222
references.citation: J Immunol. 1994 Nov 15;153(10):4508-19
references.pmid: 7525707
references.citation: J Immunol. 1984 Apr;132(4):1821-5
references.pmid: 6699403
references.citation: J Exp Med. 2009 Feb 16;206(2):313-28
references.pmid: 19204109